Vector Wealth Management’s Gilead Sciences GILD Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2016
Q2
Sell
-2,275
Closed -$209K 81
2016
Q1
$209K Sell
2,275
-926
-29% -$83.5K 0.15% 75
2015
Q4
$324K Sell
3,201
-326
-9% -$33.9K 0.25% 52
2015
Q3
$374K Buy
3,527
+234
+7% +$26K 0.29% 44
2015
Q2
$385K Sell
3,293
-270
-8% -$29.5K 0.3% 41
2015
Q1
$349K Sell
3,563
-28
-0.8% -$2.84K 0.28% 40
2014
Q4
$338K Sell
3,591
-84
-2% -$8.69K 0.25% 41
2014
Q3
$391K Buy
3,675
+467
+15% +$45.7K 0.29% 31
2014
Q2
$266K Sell
3,208
-666
-17% -$51.8K 0.2% 43
2014
Q1
$274K Hold
3,874
0.2% 37
2013
Q4
$291K Buy
3,874
+40
+1% +$2.79K 0.21% 36
2013
Q3
$241K Sell
3,834
-131
-3% -$7.83K 0.18% 51
2013
Q2
$203K Buy
+3,965
New +$207K 0.15% 54

Other funds holding GILD

Vector Wealth Management's GILD Position: Q2 2016 in Review

Vector Wealth Management sold out of Gilead Sciences (GILD) in Q2 2016, closing a stake of 2,275 shares — an estimated $209K sold.

Vector Wealth Management first reported a position in GILD in Q2 2013 and held it in 12 quarters. The position peaked at $391K in Q3 2014. 1,596 funds tracked by Wall St. Rank hold GILD as of Q2 2016.

  • Vector Wealth Management reported no remaining Gilead Sciences position as of Q2 2016 after selling out during the quarter.
  • Vector Wealth Management sold 2,275 Gilead Sciences shares in Q2 2016, an estimated $209K.
  • Vector Wealth Management first reported a position in Gilead Sciences in Q2 2013 and held it in 12 quarters.
  • Vector Wealth Management's Gilead Sciences position peaked at $391K in Q3 2014.
  • 1,596 funds tracked by Wall St. Rank held Gilead Sciences as of Q2 2016.

Based on Vector Wealth Management's 13F filing for Q2 2016, filed 26 Oct 2016.